UPDATE 1-McKesson, CD&R to buy infusion therapy provider Option Care Health in $5.8 billion deal

3

(Adds details throughout) Oct 6 (Reuters) – Drug distributor McKesson and private equity firm Clayton Dubilier & Rice on Tuesday agreed to buy infusion therapy provider Option Care Health in a deal

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)